Clinical Trial Detail

NCT ID NCT03539198
Title Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase 0
Variant Requirements No
Sponsors Mayo Clinic
Indications

laryngeal squamous cell carcinoma

nasopharynx carcinoma

skin squamous cell carcinoma

head and neck squamous cell carcinoma

pharynx squamous cell carcinoma

oral cavity cancer

paranasal sinus cancer

nasal cavity cancer

Therapies

Nivolumab

Age Groups: senior adult

No variant requirements are available.